130 related articles for article (PubMed ID: 1242748)
1. Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
Richman SP; Mavligit GM; Wolk R; Gutterman JU; Hersh EM
JAMA; 1975 Dec; 234(12):1233-5. PubMed ID: 1242748
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma.
Nathanson L; Schoenfeld D; Regelson W; Colsky J; Mittelman A
Cancer; 1979 May; 43(5):1630-5. PubMed ID: 376098
[TBL] [Abstract][Full Text] [Related]
3. Severe complications of intralesional BCG therapy in an unsensitized patient. Case report and clinical implications.
Felix EL; Jessup JM; Cohen MH
Arch Surg; 1978 Jul; 113(7):893-6. PubMed ID: 678104
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effects.
Hortobagyi GN; Richman SP; Dandridge K; Gutterman JU; Blumenschein GR; Hersh EM
Cancer; 1978 Nov; 42(5):2293-303. PubMed ID: 363257
[TBL] [Abstract][Full Text] [Related]
5. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
Coates AS; Peters M
Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
[TBL] [Abstract][Full Text] [Related]
6. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
Korting HC; Strasser S; Konz B
Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
[TBL] [Abstract][Full Text] [Related]
7. Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer.
Bodurtha A; Kim YH; Laucius JF; Donato RA; Mastrangelo MJ
Am J Clin Pathol; 1974 Jun; 61(6):747-52. PubMed ID: 4598826
[No Abstract] [Full Text] [Related]
8. Axillary lymphadenopathy: a complication of BCG immunotherapy for melanoma.
Briggs PC; Heckler FR
Plast Reconstr Surg; 1988 Jun; 81(6):952-3. PubMed ID: 3375359
[TBL] [Abstract][Full Text] [Related]
9. Letter: Malignant melanoma arising de novo within a B.C.G. scarification site.
Lokich JJ
Lancet; 1975 Feb; 1(7902):331-2. PubMed ID: 46469
[No Abstract] [Full Text] [Related]
10. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
[TBL] [Abstract][Full Text] [Related]
11. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure].
Wolf M; Menzel W; Keller G
Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966
[No Abstract] [Full Text] [Related]
12. Clinical and immunologic studies of disseminated BCG infection.
Rosenberg SA; Seipp C; Sears HF
Cancer; 1978 May; 41(5):1771-80. PubMed ID: 647627
[TBL] [Abstract][Full Text] [Related]
13. Granulomas in melanoma patients treated with BCG immunotherapy.
Hatzitheofilou C; Obenchain DF; Porter DD; Morton DL
Cancer; 1982 Jan; 49(1):55-60. PubMed ID: 7053820
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
15. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma.
O'Connor TP; Labandter HP; Hiles RW; Bodenham DC
Br J Plast Surg; 1978 Oct; 31(4):317-22. PubMed ID: 361132
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactic reaction to intralesional B.C.G.
Proctor JW; Zidar B; Pomerantz M; Yamamura Y; Eng CP; Woodside D
Lancet; 1978 Jul; 2(8081):162. PubMed ID: 78369
[No Abstract] [Full Text] [Related]
17. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
Wätzig V; Knopf B
Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
[TBL] [Abstract][Full Text] [Related]
18. Intralesional immune therapy: methanol extraction residue of BCG or purified protein derivative.
Lokich JJ; Garnick MB; Legg M
Oncology; 1979; 36(5):236-41. PubMed ID: 481845
[TBL] [Abstract][Full Text] [Related]
19. Risks of BCG intralesional therapy: an experience with melanoma.
Robinson JC
J Surg Oncol; 1977; 9(6):587-93. PubMed ID: 145518
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
Grigorovich NA; Risina DIa; Nodel'son SE
Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]